这些中西药联用,请小心!

2017-12-02 王朝蓉 中山大学附属第六医院 药学部

目前中西药联用在临床已非常普遍,但中西药也不是随便就可以联用的哦!

目前中西药联用在临床已非常普遍,但中西药也不是随便就可以联用的哦!

中西药不合理联用,会产生种种问题,如产生沉淀,降低药物疗效,或产生络合物,妨碍吸收,或产生毒性,引起疾病乃至危及生命等。

那么,你知道哪些药可以联用,那些药不能联用吗?那么我们现在一起来了解一下几个中西药联用对疗效的影响,让大家用药安全、放心!

一 .降低药物疗效

1、含钙、镁、铁等金属离子的中药与西药的不合理联用举例:

(1)含钙、镁、铁等金属离子的中药,如石膏、瓦楞子、牡蛎、龙骨、海螵蛸、石决明、赭石、明矾等及其中成药,不能与四环素类抗生素联用,因金属离子可与此类西药形成络合物,而不易被胃肠道吸收,降低疗效。

(2)含钙、镁、铁等金属离子的中药及中成药,不能与异烟肼联用,因异烟肼分子中含有肼类官能团,与上述中药同服后,既会产生螯合效应,生成异烟肼与钙、铝、镁、铁、铋的螯合物,妨碍机体吸收;又能影响酶系统发挥干扰结核杆菌代谢的作用,从而降低疗效。

(3)含钙、镁、铁等金属离子的中药或中成药,不能与左旋多巴联用,因左旋多巴中有游离酚羟基,与上述中药合用后,遇金属离子则会产生络合反应,生成左旋多巴与钙、铝、镁、铁、铋的络合物,影响其吸收,从而降低左旋多巴的生物效应。

(4)含铝、镁、铜等金属离子较多的中成药,如磁朱丸、利邦平消片、大黄清胃丸等与喹诺酮类药物合用,因螯合效应,形成螯合物,影响吸收,降低疗效。

2、碱性较强的中药及中成药与西药的不合理联用举例:

(1)碱性较强的中药及中成药,如瓦楞子、海螵蛸、朱砂等,不宜与酸性药物如胃蛋白酶合剂、阿司匹林等联用,以免因联用而使疗效降低。

(2)碱性较强的中药及中成药,不能与四环素族抗生素、奎宁等同服,因其可减少四环素族抗生素及奎宁等在肠道的吸收,使其血药浓度降低。

(3)含碱性成分的中药及中成药,不能与维生素B1同服,因其能中和胃酸而促使维生素B1的分解,从而降低维生素B1的药效。

3、酸性较强的中药及中成药与西药的不合理联用举例:

(1)酸性较强的中药,如山楂、五昧子、山茱萸、乌梅及中成药五味子糖浆、LU楂冲剂等,不可与磺胺类药物联用。因磺胺类药物在酸性条件下不会加速乙酰化的形成,从而失去抗菌作用。

(2)酸性较强的中药及中成药,不可与碱性较强的西药如氨茶碱、胃舒平、乳酸钠、碳酸氢钠等联用,因与碱性药物发生中和反应后,会降解或失去疗效。

4、含鞣质较多的中药及其中成药与西药联用不合理举例:

(1)含鞣质较多的中药及其中成药,如五倍子、地榆、诃子、石榴皮、大黄等,不可与胃蛋白酶合剂、淀粉酶、多酶片等消化酶类药物联用。因这些酶类药物的化学成分主要为蛋白质,含有肽键或胺键,极易与鞣质结合发生化学反应,形成氢键络合物而改变其性质,不易被胃肠道吸收,从而引起消化不良、纳呆等症状。

(2)含鞣质较多的中药或中成药,不可与四环素类抗生素及红霉素、利福平、灰黄霉素、制霉菌素、林可霉素、克林霉素、新霉素、氨苄西林等同时服用,因同服后可生成鞣酸盐沉淀物,不易被吸收,从而降低药物的生物利用度与疗效。

(3)含鞣质较多的中药或中成药,不可与含金属离子的西药如钙剂、铁剂、氯化钴等合用,因同服后可在回肓部结合,生成沉淀,致使机体难于吸收而降低药效。

5、含有皂苷成分的中药与西药的不合理联用举例:

(1)含有皂苷成分的中药,如人参、三七、远志、桔梗等,不宜与酸性较强的药物合用。因在酸性环境与酶的作用下,皂苷极易水解失效。

(2)含有皂苷成分的中药,不宜与含有金属离子的盐类药物如硫酸亚铁、次碳酸铋等合用,因同服后可形成沉淀,致使机体难于吸收而降低疗效。

6、其他

(1)金银花、连翘、黄芩、鱼腥草等及其中成药,不宜与菌类制剂如乳酶生、促菌生等联用,因金银花、连翘、黄芩、鱼腥草等及其中成药具有较强抗菌作用,服用后在抗菌的同时,还能抑制或降低西药菌类制剂的活性。

(2)蜂蜜、饴糖等含糖较多的中药及其制剂,不可与胰岛素、格列本脲等治疗糖尿病的西药同用,以免影响药效。

(3)含有甘草、鹿茸的中成药(如人参鹿茸丸、全鹿丸等),不能与磺酰脲类降糖药联用。因为甘草、鹿茸具有糖皮质激素样作用,有水钠潴留和排钾效应,还能促进糖原异生,加速蛋白质及脂肪的分解,使甘油、乳酸等各种糖、氨基酸转化成葡萄糖,使血糖升高,从而减弱胰岛素、甲苯磺丁脲、格列本脲等降糖药的药效。

二.产生或增加不良反

1、含有汞类的中药与西药的不合理联用举例:

(1)含汞类中药及其制剂,如朱砂、轻粉、朱砂安神丸、仁丹、紫血散、补心丹、磁朱丸等,不能与溴化钾、三溴合剂、碘化钾、碘喉片等同服,因汞离子与溴离子或碘离子在肠中相遇后,会生成有剧毒的溴化汞或碘化汞,从而导致药源性肠炎或赤痢样大便。

(2)含汞的中药或中成药,不能与具有还原性的西药如硫酸亚铁、亚硝酸异戊酯同服,同服后能使Hg2+还原成Hg+,毒性增强。

2、含有机酸类的中药与西药的不合理联用举例:

(1)含有机酸类的中药及中成药,不能与磺胺类、大环类内酯类、利福平、阿斯匹林等酸性药物合用,因尿液酸化,可使磺胺类和大环内酯类药物的溶解度降低,增加磺胺类药物的肾毒性,引起结晶尿或血尿;增加大环内酯类药物的肝毒性,甚至引起听觉障碍;可使利福平和阿斯匹林的排泄减少。加重肾脏的毒副反应。

(2)含大量有机酸的中药及其制剂,不可与呋喃妥因、利福平、阿司匹林、消炎痛等同服,因前者能增加后者在肾脏中的重吸收,从而加重对肾脏的毒性。

3、含有鞣质的中药与西药的不合理联用举例:

(1)含水合型鞣质而对肝脏有一定毒性的诃子、五倍子、地榆、四季青等,以及含有这些药物的中成药,不能与对肝脏有一定毒性的西药如四环素、利福平、氯丙嗪、异烟肼、无味红霉素等联用,因联用后会加重对肝脏的毒性,导致药源性肝病的发生。

(2)含鞣质类中药如虎杖、大黄、诃子、五倍子等,不能与磺胺类西药同服,因鞣质能与磺胺类药物结合,影响磺胺的排泄,导致血及肝内磺胺药浓度增高,严重者可发生中毒性肝炎。

4、含有碱性成分的中药与西药的不合理联用举例:

(1)含碱性成分的中药及其制剂,不能与氨基糖苷类西药合用,因这些中药及其制剂能使机体对氨基糖苷类抗生素吸收增加,排泄减少,虽能提高抗生素的抗菌药力,但却增加了其在脑组织中的药物浓度,使耳毒性作用增强,从而影响前庭功能,导致暂时或永久性耳聋及行动蹒跚。

(2)含碱性成分的中药及其制剂,不能与奎尼丁同用,因其能使尿液碱化,增加肾小管对奎尼丁的重吸收,从而使排泄减少,血药浓度增加,引发奎尼丁中毒。

(3)含颠茄类生物碱的中药及其制剂,如曼陀罗、洋金花、天仙子、颠茄合剂等;含有钙离子的中药,如石膏、牡蛎、龙骨等,均不可与强心苷类药物联用,因颠茄类生物碱可松弛平滑肌,降低胃肠道的蠕动,与此同时也就增加了强心苷类药物的吸收和蓄积,故增加了毒性。

5、含有乙醇的中药与西药的不合理联用举例:

(1)含乙醇的中成药如各种药酒等,不可与镇静剂如苯巴比妥、苯妥英钠、安乃近等联用,因联用后既可产生具有毒性的醇合三氯乙醛,又能抑制中枢神经系统,引起呼吸困难、心悸、焦虑、面红等不良反应,严重者可致死亡。

(2)含乙醇的中成药如各种药酒等,不可与阿司匹林、水杨酸钠等抗风湿药同服,因乙醇与水杨酸等对消化道均有刺激作用,同用后能增加对消化道的刺激性,严重者可导致胃肠出血。

(3)含乙醇的中成药如各种药酒等,不可与三环类抗抑郁药丙米嗪、阿米替林、氯丙米嗪、多虑平等同服,因前者可加快后者的代谢,从而增强三环类抗抑郁药毒性,甚至导致死亡。

(4)含乙醇的中成药如各种药酒等,不可与抑制乙醇代谢的氯丙嗪、奋乃静、氟奋乃静、三氟拉嗪等吩噻类西药同用,因后者能使前者分解缓慢,加重恶心、呕吐、头痛、颜面潮红等中毒症状。

(5)含乙醇的中成药如各种药酒等,不可与胍乙啶、利血平、肼苯达嗪、甲基多巴及妥拉苏林等抗高血压药联用,因同用后易产生协同作用引起体位性低血压。

(6)含乙醇的中成药如各种药酒等,不可与扑热息痛同服,因同用后二者的代谢产物对肝脏损害严重,有些患者对此类药极为敏感,从而可引起肝坏死及急性肾功能衰竭。

(7)含乙醇的中成药如各种药酒等,不可与抗组胺类药如氯苯那敏等联用,因同用后能增强对中枢神经系统的抑制,导致熟练技能障碍、困倦等不良反应等。

(8)含乙醇的中成药如各种药酒等,不可与胰岛素及磺脲类降糖西药同用或同服。因联用后会导致严重的低血糖,或头晕、呕吐,严重者可出现昏睡等酩酊反应,甚至出现不可逆性神经系统症状等。

(9)含乙醇的中成药如各种药酒等,不可与磺胺及呋喃类抗生素联用,因这两类西药均能抑制乙醇在体内的代谢,增加乙醇对机体的毒性作用,严重者亦可出现酩酊反应,而所含乙醇又能加重这两类西药对中枢神经的毒性。

(10)含乙醇的中成药如各种药酒等,不可与硝酸甘油等扩张血管类西药同用,因所含乙醇对交感神经和血管运动中枢有抑制作用,致使心肌收缩力减弱,血管扩张,从而与硝酸甘油的扩张血管作用产生协同作用,导致血压明显降低。

6、其他

(1)含朱砂的中药及其制剂,诸如朱砂安神丸、六神丸、安宫牛黄丸、苏合香丸、万氏牛黄清心丸、仁丹等不宜与还原性西药(溴化钾、溴化纳、碘化钾、碘化纳)配伍用,否则会产生溴化汞、溴化钠等沉淀物而严重刺激肠壁引起排出赤痢样大便,可导致药源性肠炎。

(2)海藻、昆布等含碘类中药及其制剂,不宜与治疗甲状腺功能亢进的西药联用。因其所含的碘能促进酪氨酸的碘化,使体内甲状腺素的合成增加,不利于治疗。

(3)黄药子对肝脏有一定毒性,不可与利福平、四环素、红霉素、氯丙嗪等本身也具有肝毒性的西药联用,以免引发药源性肝病。

(4)含鹿茸的中成药不宜与降血糖西药(胰岛素、降糖灵等)合用。如鹿茸胶(片)、参茸片、参茸固本片等,因鹿茸中含有糖皮质激素样物质,可使血糖升高,从而减弱降血糖药的疗效。

(5)含钙的中药与氨基糖苷类抗生素不能同用。庆大霉素、妥布霉素、奈替米星等氨基糖苷类抗生素能与钙离子结合,若与含钙中药联用,会增加氨基糖苷类药物的神经毒性。含钙中药有龙骨、牡蛎、海螵蛸、鹿角、枸杞等。

三.毒性增加或相加

(1)含强心苷类中药,如罗布麻、夹竹桃、羊角拗等与强心苷类西药合用;

(2)含钾较高的中药,如篇蓄、泽泻、白茅根、金钱草、丝瓜络等及其制剂与氯化钾注射液合用;

(3)鹿茸及其制剂与排钾性利尿药,如氢氯噻嗪、利尿酸、呋塞米等的联用,极易导致毒副作用的协同增加。

(4)发汗解表药如荆芥、麻黄、生姜等及其制剂,如防风通圣丸与解热镇痛药(如阿司匹林、扑热息痛)等合用可致发汗太过,产生虚脱。

(5)碱性中药及其制剂,因能碱化尿液,若联用奎尼丁,会降低后者排泄,引起中毒;若联用氨基糖苷类抗生素,会增加后者被吸收量,增强其对听神经的损害。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=267162, encodeId=8f1426e16208, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Wed Dec 06 06:40:23 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555614, encodeId=8145155561436, content=<a href='/topic/show?id=dcd89053994' target=_blank style='color:#2F92EE;'>#西药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90539, encryptionId=dcd89053994, topicName=西药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4014636852, createdName=minzju5057, createdTime=Mon Dec 04 14:26:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266438, encodeId=a50d26643808, content=万物相生相克, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Dec 03 11:01:36 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266409, encodeId=9b932664090a, content=好资料.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sun Dec 03 08:55:19 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266375, encodeId=cd322663e540, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Dec 03 07:11:38 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266361, encodeId=8b76266361b0, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Dec 03 06:35:31 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266313, encodeId=3cd326631378, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Dec 03 00:03:58 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266304, encodeId=c8e3266304c3, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sat Dec 02 23:53:50 CST 2017, time=2017-12-02, status=1, ipAttribution=)]
    2017-12-06 txqjm

    谢谢了.学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=267162, encodeId=8f1426e16208, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Wed Dec 06 06:40:23 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555614, encodeId=8145155561436, content=<a href='/topic/show?id=dcd89053994' target=_blank style='color:#2F92EE;'>#西药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90539, encryptionId=dcd89053994, topicName=西药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4014636852, createdName=minzju5057, createdTime=Mon Dec 04 14:26:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266438, encodeId=a50d26643808, content=万物相生相克, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Dec 03 11:01:36 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266409, encodeId=9b932664090a, content=好资料.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sun Dec 03 08:55:19 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266375, encodeId=cd322663e540, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Dec 03 07:11:38 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266361, encodeId=8b76266361b0, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Dec 03 06:35:31 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266313, encodeId=3cd326631378, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Dec 03 00:03:58 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266304, encodeId=c8e3266304c3, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sat Dec 02 23:53:50 CST 2017, time=2017-12-02, status=1, ipAttribution=)]
    2017-12-04 minzju5057
  3. [GetPortalCommentsPageByObjectIdResponse(id=267162, encodeId=8f1426e16208, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Wed Dec 06 06:40:23 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555614, encodeId=8145155561436, content=<a href='/topic/show?id=dcd89053994' target=_blank style='color:#2F92EE;'>#西药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90539, encryptionId=dcd89053994, topicName=西药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4014636852, createdName=minzju5057, createdTime=Mon Dec 04 14:26:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266438, encodeId=a50d26643808, content=万物相生相克, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Dec 03 11:01:36 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266409, encodeId=9b932664090a, content=好资料.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sun Dec 03 08:55:19 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266375, encodeId=cd322663e540, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Dec 03 07:11:38 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266361, encodeId=8b76266361b0, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Dec 03 06:35:31 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266313, encodeId=3cd326631378, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Dec 03 00:03:58 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266304, encodeId=c8e3266304c3, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sat Dec 02 23:53:50 CST 2017, time=2017-12-02, status=1, ipAttribution=)]
    2017-12-03 lyh994

    万物相生相克

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=267162, encodeId=8f1426e16208, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Wed Dec 06 06:40:23 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555614, encodeId=8145155561436, content=<a href='/topic/show?id=dcd89053994' target=_blank style='color:#2F92EE;'>#西药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90539, encryptionId=dcd89053994, topicName=西药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4014636852, createdName=minzju5057, createdTime=Mon Dec 04 14:26:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266438, encodeId=a50d26643808, content=万物相生相克, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Dec 03 11:01:36 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266409, encodeId=9b932664090a, content=好资料.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sun Dec 03 08:55:19 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266375, encodeId=cd322663e540, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Dec 03 07:11:38 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266361, encodeId=8b76266361b0, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Dec 03 06:35:31 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266313, encodeId=3cd326631378, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Dec 03 00:03:58 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266304, encodeId=c8e3266304c3, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sat Dec 02 23:53:50 CST 2017, time=2017-12-02, status=1, ipAttribution=)]
    2017-12-03 惠映实验室

    好资料.学习了.

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=267162, encodeId=8f1426e16208, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Wed Dec 06 06:40:23 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555614, encodeId=8145155561436, content=<a href='/topic/show?id=dcd89053994' target=_blank style='color:#2F92EE;'>#西药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90539, encryptionId=dcd89053994, topicName=西药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4014636852, createdName=minzju5057, createdTime=Mon Dec 04 14:26:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266438, encodeId=a50d26643808, content=万物相生相克, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Dec 03 11:01:36 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266409, encodeId=9b932664090a, content=好资料.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sun Dec 03 08:55:19 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266375, encodeId=cd322663e540, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Dec 03 07:11:38 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266361, encodeId=8b76266361b0, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Dec 03 06:35:31 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266313, encodeId=3cd326631378, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Dec 03 00:03:58 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266304, encodeId=c8e3266304c3, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sat Dec 02 23:53:50 CST 2017, time=2017-12-02, status=1, ipAttribution=)]
    2017-12-03 Y—xianghai

    学习了新知识

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=267162, encodeId=8f1426e16208, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Wed Dec 06 06:40:23 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555614, encodeId=8145155561436, content=<a href='/topic/show?id=dcd89053994' target=_blank style='color:#2F92EE;'>#西药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90539, encryptionId=dcd89053994, topicName=西药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4014636852, createdName=minzju5057, createdTime=Mon Dec 04 14:26:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266438, encodeId=a50d26643808, content=万物相生相克, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Dec 03 11:01:36 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266409, encodeId=9b932664090a, content=好资料.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sun Dec 03 08:55:19 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266375, encodeId=cd322663e540, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Dec 03 07:11:38 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266361, encodeId=8b76266361b0, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Dec 03 06:35:31 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266313, encodeId=3cd326631378, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Dec 03 00:03:58 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266304, encodeId=c8e3266304c3, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sat Dec 02 23:53:50 CST 2017, time=2017-12-02, status=1, ipAttribution=)]
    2017-12-03 yjs木玉

    好好好好好好好好

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=267162, encodeId=8f1426e16208, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Wed Dec 06 06:40:23 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555614, encodeId=8145155561436, content=<a href='/topic/show?id=dcd89053994' target=_blank style='color:#2F92EE;'>#西药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90539, encryptionId=dcd89053994, topicName=西药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4014636852, createdName=minzju5057, createdTime=Mon Dec 04 14:26:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266438, encodeId=a50d26643808, content=万物相生相克, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Dec 03 11:01:36 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266409, encodeId=9b932664090a, content=好资料.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sun Dec 03 08:55:19 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266375, encodeId=cd322663e540, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Dec 03 07:11:38 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266361, encodeId=8b76266361b0, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Dec 03 06:35:31 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266313, encodeId=3cd326631378, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Dec 03 00:03:58 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266304, encodeId=c8e3266304c3, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sat Dec 02 23:53:50 CST 2017, time=2017-12-02, status=1, ipAttribution=)]
    2017-12-03 飛歌

    学习了很有用不错

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=267162, encodeId=8f1426e16208, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Wed Dec 06 06:40:23 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555614, encodeId=8145155561436, content=<a href='/topic/show?id=dcd89053994' target=_blank style='color:#2F92EE;'>#西药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90539, encryptionId=dcd89053994, topicName=西药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4014636852, createdName=minzju5057, createdTime=Mon Dec 04 14:26:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266438, encodeId=a50d26643808, content=万物相生相克, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Dec 03 11:01:36 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266409, encodeId=9b932664090a, content=好资料.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sun Dec 03 08:55:19 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266375, encodeId=cd322663e540, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Dec 03 07:11:38 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266361, encodeId=8b76266361b0, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Dec 03 06:35:31 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266313, encodeId=3cd326631378, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Dec 03 00:03:58 CST 2017, time=2017-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266304, encodeId=c8e3266304c3, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sat Dec 02 23:53:50 CST 2017, time=2017-12-02, status=1, ipAttribution=)]
    2017-12-02 戒馋,懒,贪

    谢谢分享学习了

    0

相关资讯

国家局连发4通告,这些药有问题!

年末将至,又到了各药企准备年终总结的时候。而药品质量等的严查,药监部门可是没有丝毫松懈。瞧,近日,国家食药监总局官网一天之内弹出了四条药品质量通告,共涉及84批次药品。

部分中药制剂无需临床试验即可上市 《自然》刊文表忧虑

《自然》文章认为,中国对中药遇到的各种问题讨论不足,一些中药相关的医疗事故已经给中医的安全性打上了问号 原图11月29日,学术杂志《自然》发表一篇由记者David Cyranoski撰写的文章,对中国国家食品药品监督管理总局10月公布的《中药经典名方复方制剂简化注册审批管理规定》表达了忧虑。图/视觉中国 11月29日,学术杂志《自然》发表一篇由记者David Cyranoski撰写的文章,

国家卫计委:发展中医药特色医养 鼓励社会资本进入

11月15日,国家卫生计生委发布了《“十三五”健康老龄化规划重点任务分工》的通知(下称《通知》),明确指出了包含国家卫生计生委等在内在13部门关于“十三五”健康老龄化规划重点任务的分工。

传统中药或将不再需要通过临床试验,部分科学家表示担忧

原文以China rolls back regulations for traditional medicine despite safety concerns为标题发布在2017年11月29日的《自然》新闻上原文作者:David Cyranoski科学家担心授予古代中药疗法临床试验的豁免权会带来风险。中国政府对中药的支持再上一层楼。习近平主席将其称为中国古代科学的瑰宝,并保证给予非传统疗法和西药

BMC Complement Altern Med:中药玉屏风散对成年人过敏性鼻炎治疗效果的研究

中药玉屏风散(YPFS)经常用于过敏性鼻炎(AR)的治疗。之前的综述总结了YPFS的治疗效果和安全性,然而却没有亚群的分析来提供指导临床实践的详细证据。YPFS在中药临床实践指南中推荐作为治疗AR的药物,但是YPFS的治疗时间并没有特别的陈述。最近,有研究人员进行了旨在评估YPFS在治疗成年人AR中的效果和安全性的研究,并利用了最新的证据,并且还在亚群元分析中尝试确定YPFS的使用时间。研究发现,

中药注射剂、生化药大检查!

昨日(11月10日),黑龙江省药监局印发《黑龙江省2017年生化药品及中药注射剂专项检查工作方案》(以下简称方案),将对全省所有生化药品及中药注射剂药品生产企业进行检查。